Healthy Extracts (HYEX) Non-Current Assets (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Non-Current Assets came in at $26.5 million in Q4 2025, up 3587.43% year-on-year from $718586.0 in Q4 2024, and up 8.32% quarter-over-quarter from $24.5 million in Q3 2025.
Healthy Extracts (HYEX) Non-Current Assets (2015 - 2025) Analysis & Trends
Healthy Extracts' Non-Current Assets history runs 11 years deep, the most recent figure standing at $26.5 million for Q4 2025.
- On a quarterly basis, Non-Current Assets rose 3587.43% year-over-year to $26.5 million in Q4 2025; TTM through Dec 2025 was $52.8 million, a 1756.6% increase from a year earlier, with the FY2025 full-year figure at $26.5 million, up 3587.43% from the prior year.
- Non-Current Assets rose to $26.5 million in Q4 2025 per HYEX's latest filing, from $24.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $26.5 million in Q4 2025 and bottomed at -$2.2 million in Q1 2022.
- The 5-year median for Non-Current Assets is $678996.5 (2021), against an average of $2.4 million.
- Across the five-year window, Non-Current Assets sank 545.28% in 2024 and surged 8574.77% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $716175.0 in 2021, then advanced by 2.98% to $737531.0 in 2022, then fell by 0.3% to $735336.0 in 2023, then decreased by 2.28% to $718586.0 in 2024, then soared by 3587.43% to $26.5 million in 2025.
- Per Business Quant, the three latest HYEX Non-Current Assets figures stand at $26.5 million (Q4 2025), $24.5 million (Q3 2025), and $934894.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.50 Mn |
| Sep 30, 2025 | 24.46 Mn |
| Jun 30, 2025 | 934,894.00 |
| Mar 31, 2025 | 930,805.00 |
| Dec 31, 2024 | 718,586.00 |
| Sep 30, 2024 | -288,653.00 |
| Jun 30, 2024 | -1.75 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | 735,336.00 |
| Sep 30, 2023 | -377,096.00 |
| Jun 30, 2023 | -271,008.00 |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | 737,531.00 |
| Sep 30, 2022 | -174,639.00 |
| Jun 30, 2022 | -152,806.00 |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | 716,175.00 |
| Sep 30, 2021 | 706,334.00 |
| Jun 30, 2021 | 696,109.00 |
| Mar 31, 2021 | 661,884.00 |